Price
$0.09
Decreased by -1.56%
Dollar volume (20D)
13.50 K
ADR%
33.18
Shares float
2.93 M
Shares short
22.21 K [0.76%]
Shares outstanding
0.00
Market cap
N/A
Beta
-1.05
Price/earnings
N/A
20D range
0.03 0.11
50D range
0.01 0.11
200D range
0.01 0.43

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

The company offers inflammatory response to fend off infections and repair damaged tissue in the body.

It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.

The company is headquartered in Denver, Colorado.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 0.00
Decreased by N/A%
-7.43 M
Decreased by -292.49%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-3.67 M
Decreased by -306.76%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-5.26 M
Decreased by -424.10%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
-19.21 M
Decreased by -1.64 K%
Decreased by N/A%
-
Sep 30, 22 0.00
Decreased by N/A%
-1.89 M
Decreased by -77.65%
Decreased by N/A%
-
Jun 30, 22 0.00 - -902.00 K -
Decreased by N/A%
-
Mar 31, 22 0.00 - -1.00 M -
Decreased by N/A%
-
Jun 30, 21 N/A - -1.11 M - - -
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY